The dangers of using anti-diabetes drugs as a weight loss shortcut were highlighted in a recent Corriere Salute meeting titled “Antidiabetics that help you lose weight: who really needs them?” Experts warned against the improper use of GLP1 agonists, which have gained popularity on social media as miracle weight loss medications.
Professor Anna Ludovica Fracanzani emphasized the risks of taking these drugs without a clinical need, stating that they can lead to serious side effects and even muscle mass loss if not used properly. Riccardo Candido, president of the Association of Diabetologists, warned against buying these drugs online, as they may not be genuine GLP1 agonists and could pose serious health risks.
The approved clinical indications for GLP1 agonists were also discussed by Candido and Luca Busetto, vice-president of the European Association for the Study of Obesity. These drugs are primarily used to treat type 2 diabetes and obesity in patients with certain medical conditions, such as high cardiovascular risk or metabolic syndrome.
Experts emphasized that GLP1 agonists should not be used solely for weight loss, but rather to improve overall health and reduce health risks associated with diabetes and obesity. They explained how these drugs work to control blood sugar levels and reduce weight by increasing satiety and reducing hunger.
In conclusion, the experts highlighted the importance of understanding the proper use of GLP1 agonists and the potential risks of using them without a clinical indication. It is crucial to consult a healthcare professional before considering using these medications for weight loss purposes.